Northern Trust’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.26M | Buy |
820,164
+680,832
| +489% | +$4.36M | ﹤0.01% | 2437 |
|
|
2025
Q1 | $493K | Buy |
139,332
+32,768
| +31% | +$116K | ﹤0.01% | 3584 |
|
|
2024
Q4 | $403K | Buy |
106,564
+11,214
| +12% | +$42.4K | ﹤0.01% | 3734 |
|
|
2024
Q3 | $309K | Sell |
95,350
-271,899
| -74% | -$881K | ﹤0.01% | 3727 |
|
|
2024
Q2 | $698K | Sell |
367,249
-58,318
| -14% | -$111K | ﹤0.01% | 3382 |
|
|
2024
Q1 | $1.21M | Sell |
425,567
-9,870
| -2% | -$28K | ﹤0.01% | 3235 |
|
|
2023
Q4 | $6.41M | Buy |
435,437
+9,659
| +2% | +$142K | ﹤0.01% | 2356 |
|
|
2023
Q3 | $7.8M | Sell |
425,778
-59,640
| -12% | -$1.09M | ﹤0.01% | 2166 |
|
|
2023
Q2 | $10.5M | Buy |
485,418
+21,538
| +5% | +$465K | ﹤0.01% | 2035 |
|
|
2023
Q1 | $13.6M | Buy |
463,880
+68,741
| +17% | +$2.02M | ﹤0.01% | 1810 |
|
|
2022
Q4 | $14.6M | Buy |
395,139
+109,331
| +38% | +$4.04M | ﹤0.01% | 1750 |
|
|
2022
Q3 | $8.05M | Buy |
285,808
+191,267
| +202% | +$5.38M | ﹤0.01% | 2149 |
|
|
2022
Q2 | $1.82M | Buy |
94,541
+12,371
| +15% | +$238K | ﹤0.01% | 3115 |
|
|
2022
Q1 | $1.06M | Buy |
+82,170
| New | +$1.06M | ﹤0.01% | 3395 |
|